HBFOTC FILING WATCHBY HONGBO FINANCELIVE WIREOFFICIAL SEC RECORDS · FINRA OTC DAILY LIST
AUTOMATED SEC FILING DILIGENCE BRIEF
PUBLIC-RECORD DELIVERY

Inhibitor Therapeutics, Inc.

CIK 0001042418Ticker INTISEC observed OTC

Automatically organized from the issuer’s official SEC submissions index. This brief is the starting evidence layer for buyer, FA, legal and broker-dealer review—not a legal conclusion or safety rating.

Reporting & material events77

captured official filings

Registration & offering2

captured official filings

Ownership79

captured official filings

Governance2

captured official filings

PRIORITY FILING CUES

What to review next

Rules are applied to retained SEC filing types in this issuer record. They prioritize reading work; they are not ratings or conclusions.

No retained filing in the latest 16 records matched the current priority rules. This is not clearance; review the official timeline for context.

WHAT THIS AUTOMATES

One evidence index instead of a manual filing hunt.

It groups recent reporting, registration/offer, ownership and governance filings, preserves the SEC source link and keeps a reusable chronology in the issuer’s record.

PROFESSIONAL DELIVERY LAYER

What teams can pay to automate next.

Cross-version text comparison, monitored alerts, change-specific diligence questions, CSV/PDF exports and a shared deal-team brief are the professional workflow built on this public evidence layer.

MACHINE-DETECTED FILING CHANGE RADAR

Public registration text delta

Comparing S-1/A filed 2016-07-18 with S-1/A filed 2016-07-21.

35latest comparable sentences
27new-text candidates
51prior-text candidates not found

Tracked-term count changes

Counts are navigation signals, not conclusions. Open both official filings to determine materiality.

  • shares40 → 24-16
  • offering12 → 8-4
  • proceeds3 → 0-3
  • risk factor3 → 0-3
  • management3 → 0-3
  • related party1 → 0-1

Candidate disclosure excerpts

Only sentence-level additions or removals containing tracked diligence terms are shown. These are reading cues, not materiality findings.

New in latest filing
  • EXPLANATORY NOTE This Amendment No. 2 to the Registration Statement is being filed to update the Calculation of Registration Fee Table to reflect the reduction in the number of shares registered under this Registration Statement and to attach a revised Exhibit 5.2.
  • RECENT SALES OF UNREGISTERED SECURITIES On August 13, 2013, we issued to Hedgepath, LLC, as consideration for the contribution of certain assets as described in that certain contribution agreement, dated August 13, 2013 by and between us and Hedgepath, LLC, an aggregate of 170,000.739 shares of Series A Preferred Stock which hav
  • Pursuant to such agreement, Hedgepath, LLC purchased 20,000,000 shares of our common stock at a purchase price of $0.075 per share for an aggregate purchase price of $1,500,000.
Present in earlier filing, not found in latest
  • This registration does not mean that the selling stockholders named herein will actually offer or sell any of these shares.
  • We will not receive any proceeds from the resale of the above shares of our common stock by the selling shareholders.
  • However, we may receive proceeds from the exercise of the warrants exercised other than pursuant to any applicable cashless exercise provisions of the warrants.

Method: readable plain text is extracted from two official SEC HTML filings, then compared at sentence and tracked-term level. Formatting, exhibit differences and boilerplate may create false positives. This radar is not legal advice, a disclosure completeness opinion or a transaction recommendation.

ISSUER REVIEW PLAN

What to verify next

Generated from retained official filing types and chronology. This is a work sequence, not legal, accounting, compliance, investment or transaction advice.

  1. Current disclosure path (15 retained)
    Open the retained current reports and identify the reported item, effective date and later update.
  2. Financial & ownership record (65 retained)
    Review periodic financial, ownership and governance records in their original filing context.

A dated Download Edition preserves this source-linked view for a project file.

DOWNLOAD SCOPE

Know what the paid record contains.

This is a dated working copy of the public issuer record, organized for a project file—not a separate data feed or an opinion.

189 retained SEC filingsLatest retained filing: 2026-11-16.Printable HTML record + CSV official-source indexOne issuer · one payment · no account

Best when you need to preserve what was visible, attach it to a project, or hand a source-linked record to a colleague, counsel or internal reviewer.

DOWNLOAD EDITION

Turn this issuer page into a project-file deliverable.

US$29 one time. For the moment you need to preserve the official record, hand it to a colleague or attach it to a deal file. No subscription, account or recurring charge. Download begins in this browser after payment is verified.

  • Source-linked filing chronology and registration path
  • Filing-change radar plus financing, legal, tax/lien and regulatory disclosure cues
  • Official-source index for project-file archiving and downloadable CSV export
Best used whenYou need a dated, source-linked issuer record for a client, counsel, broker-dealer or internal review file.

Pay once · verified PayPal checkout · immediate HTML and CSV delivery.

AUTOMATED EVIDENCE SNAPSHOT

Save this source-linked record

Download a printable HTML snapshot of the current public-record timeline and change view. A one-time download unlocks a saveable issuer record. Official sources remain controlling.

Unlock download · US$29
DISCLOSURE CONTEXT SCREEN

Specific public-record cues, separated from generic language

Reads selected SEC filing text by sentence. Contents-page labels, generic risk language and allocation discussion are excluded; historical financing language is kept separate.

No specific event cue was extracted from 3 readable recent SEC filings. This is not a conclusion that no event exists.

1 historical-context cue · not treated as current events
  1. FINANCING

    The Company now proposes the rate and response of surgically eligible basal cell carcinomas, meaning those tumors that have reached the anatomic site-referenced size at which surgical excision is warranted, in place of the per-lesion response rate it had previously proposed.

    10-Q · 2026-08-14 · official SEC source ↗

Scope: automated text screening of selected SEC filings only. Each cue requires review of the linked filing; it does not confirm a claim, legal status, tax status, financing completion or current issuer condition.

LEGACY TERM SCREEN · SOURCE INDEX

Financing, legal and disclosure cues

This screen counts source documents with a reading cue, never the number of underlying events. A cue may be generic risk language; open the cited SEC source before drawing any conclusion.

View screened SEC sources (4)
10-Q · 2026-11-168-K · 2026-09-1810-Q · 2026-08-1410-Q · 2026-05-15

Coverage boundary: this is a keyword screen of selected SEC filings only. It is not a court-docket search, tax-compliance review, lien clearance, sanctions screen, adverse-media search or a complete count of financings. A zero result means no matching term in the readable documents screened—not that the underlying issue is absent. Verify each cue in the linked official filing and use the appropriate independent professionals.

CAPITAL & OFFERING RECORD

Official filing path for financing review

Registration, amendment, prospectus, shelf and current-report nodes are organized here as a reading path. Use the SEC source for terms, status and materiality.

Browse all captured financing filings →
2registration / amendment nodes
1prospectus nodes
0shelf / follow-on nodes
42current-report nodes to review
  1. 8-K
    Current report — review financing contextOpen SEC source →
  2. 8-K
    Current report — review financing contextOpen SEC source →
  3. 8-K
    Current report — review financing contextOpen SEC source →
  4. 8-K
    Current report — review financing contextOpen SEC source →
  5. 8-K
    Current report — review financing contextOpen SEC source →
  6. 8-K
    Current report — review financing contextOpen SEC source →
  7. 8-K
    Current report — review financing contextOpen SEC source →
  8. 8-K
    Current report — review financing contextOpen SEC source →
  9. 8-K
    Current report — review financing contextOpen SEC source →
  10. 8-K
    Current report — review financing contextOpen SEC source →
  11. 8-K
    Current report — review financing contextOpen SEC source →
  12. 8-K
    Current report — review financing contextOpen SEC source →
  13. 8-K
    Current report — review financing contextOpen SEC source →
  14. 8-K
    Current report — review financing contextOpen SEC source →
  15. 8-K
    Current report — review financing contextOpen SEC source →
  16. 8-K
    Current report — review financing contextOpen SEC source →
  17. 8-K
    Current report — review financing contextOpen SEC source →
  18. 8-K
    Current report — review financing contextOpen SEC source →
  19. 8-K
    Current report — review financing contextOpen SEC source →
  20. 8-K
    Current report — review financing contextOpen SEC source →
  21. 8-K
    Current report — review financing contextOpen SEC source →
  22. 8-K
    Current report — review financing contextOpen SEC source →

Interpretation boundary: filing counts are not financing-round counts, proceeds, closing status or current capitalization. A registration, prospectus or report can relate to different purposes; use the linked official filing and appropriate advisers to verify each event.

KEY OFFERING LANGUAGE

What the latest offering documents say

Candidate sentence excerpts from readable official SEC filing text. This provides a fast reading layer for offering structure and terms; it is not a normalized term sheet or a transaction conclusion.

CANDIDATE LANGUAGE OBSERVED

Offering structure

Candidate language describing the securities or registration structure.

“This registration does not mean that the selling stockholders named herein will actually offer or sell any of these shares.”
424B3 · 2016-07-26 · Open SEC source →
CANDIDATE LANGUAGE OBSERVED

Shares / price

Candidate language about shares, units or offering-price terms.

“, or Mayne Pharma, participated in the 2016 Private Placement but is not registering any of its securities herein); (ii) 466,000 shares of common stock underlying warrants issued to FINRA-member agents that assisted in securing investors for the 2016 Private Placement; (iii) 20,000,000 shares of common stock issued in connection with our June 24, 2014 private placement with Hedgepath, LLC, a Florida limited liability company a”
424B3 · 2016-07-26 · Open SEC source →
CANDIDATE LANGUAGE OBSERVED

Use of proceeds

Candidate language describing stated proceeds or intended use.

“Page Prospectus Summary 1 Risk Factors 7 Cautionary Note Regarding Forward-Looking Statements 29 Use of Proceeds 30 Dividend Policy 30 Determination of Offering Price 30 Market for Common Equity and Related Stockholder Matters 30 Management’s Discussion and Analysis of Financial Condition and Results of Operations 32 Business 36 Management 54 Certain Relationships and Related Party Transactions 61 Principal Stockholders 6”
424B3 · 2016-07-26 · Open SEC source →
CANDIDATE LANGUAGE OBSERVED

Convertible / warrant terms

Candidate language about conversion, warrants or related instruments.

“Such purchase price is payable as follows: (i) an advance payment of $125,000 made by Hedgepath, LLC on June 4, 2014 was deemed partial funding of the purchase price; (ii) a payment of $125,000 was made by Hedgepath, LLC on June 24, 2014; and (iii) the remaining $1,250,000 will be funded in monthly installments through December 31, 2014 pursuant to a promissory note issued by Hedgepath, LLC to us.”
S-1/A · 2016-07-21 · Open SEC source →
View offering documents screened (3)
424B3 · 2016-07-26S-1/A · 2016-07-21S-1/A · 2016-07-18

Extraction boundary: wording can be incomplete, duplicated, conditional or superseded by later filings. The system does not calculate proceeds, share counts, dilution or closing status from these excerpts. Verify every term in the linked official SEC filing.

OFFICIAL SEC SUBMISSIONS

Captured filing chronology

Open Evidence Snapshot →
  1. 10-Q
    Reporting & material eventsOpen SEC filing →
  2. 8-K
    Reporting & material eventsOpen SEC filing →
  3. DEF 14A
    GovernanceOpen SEC filing →
  4. 10-Q
    Reporting & material eventsOpen SEC filing →
  5. 4
    OwnershipOpen SEC filing →
  6. 4
    OwnershipOpen SEC filing →
  7. 4
    OwnershipOpen SEC filing →
  8. 4
    OwnershipOpen SEC filing →
  9. 4
    OwnershipOpen SEC filing →
  10. 4
    OwnershipOpen SEC filing →
  11. 4
    OwnershipOpen SEC filing →
  12. 10-Q
    Reporting & material eventsOpen SEC filing →
  13. 8-K
    Reporting & material eventsOpen SEC filing →
  14. 8-K
    Reporting & material eventsOpen SEC filing →
  15. 10-K
    Reporting & material eventsOpen SEC filing →
  16. 8-K
    Reporting & material eventsOpen SEC filing →
  17. 10-Q
    Reporting & material eventsOpen SEC filing →
  18. 8-K
    Reporting & material eventsOpen SEC filing →
  19. 10-Q
    Reporting & material eventsOpen SEC filing →
  20. 10-Q
    Reporting & material eventsOpen SEC filing →
  21. 4
    OwnershipOpen SEC filing →
  22. 4
    OwnershipOpen SEC filing →
  23. 4
    OwnershipOpen SEC filing →
  24. 4
    OwnershipOpen SEC filing →
  25. 4
    OwnershipOpen SEC filing →
  26. 10-K
    Reporting & material eventsOpen SEC filing →
  27. 5
    OwnershipOpen SEC filing →
  28. 5
    OwnershipOpen SEC filing →
  29. 10-Q
    Reporting & material eventsOpen SEC filing →
  30. 10-Q
    Reporting & material eventsOpen SEC filing →
  31. 4
    OwnershipOpen SEC filing →
  32. 4
    OwnershipOpen SEC filing →
  33. 4
    OwnershipOpen SEC filing →
  34. 4
    OwnershipOpen SEC filing →
  35. 4
    OwnershipOpen SEC filing →
  36. 10-Q
    Reporting & material eventsOpen SEC filing →
  37. 10-K
    Reporting & material eventsOpen SEC filing →
  38. 8-K
    Reporting & material eventsOpen SEC filing →
  39. 10-Q
    Reporting & material eventsOpen SEC filing →
  40. 8-K
    Reporting & material eventsOpen SEC filing →
  41. 4
    OwnershipOpen SEC filing →
  42. 3
    OwnershipOpen SEC filing →
  43. 8-K
    Reporting & material eventsOpen SEC filing →
  44. 10-Q
    Reporting & material eventsOpen SEC filing →
  45. 8-K
    Reporting & material eventsOpen SEC filing →
  46. SC 13D
    OwnershipOpen SEC filing →
  47. SC 13G
    OwnershipOpen SEC filing →
  48. 3
    OwnershipOpen SEC filing →
  49. SC 13G
    OwnershipOpen SEC filing →
  50. 4
    OwnershipOpen SEC filing →
  51. 3
    OwnershipOpen SEC filing →
  52. 4
    OwnershipOpen SEC filing →
  53. 10-Q
    Reporting & material eventsOpen SEC filing →
  54. 10-K
    Reporting & material eventsOpen SEC filing →
  55. 3
    OwnershipOpen SEC filing →
  56. 3
    OwnershipOpen SEC filing →
  57. 3
    OwnershipOpen SEC filing →
  58. 3
    OwnershipOpen SEC filing →
  59. 3
    OwnershipOpen SEC filing →
  60. 8-K
    Reporting & material eventsOpen SEC filing →
Evidence boundary

Only official SEC submission-index facts are automated here. The brief does not determine shell status, beneficial ownership, capitalization, legal compliance, valuation, active-trading status or transaction suitability. Those questions require the appropriate source documents and independently retained professionals.